Skip to content
Recall Observatory FDA recall evidence

Drug product

Fluoxetine Capsules USP, 10 mg, in 100-count bottles, Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland, Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960. NDC 50111-647-01

D-0970-2015

April 13, 2015

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 70976
Status
Terminated
Classification
Class II
Quantity
Unavailable
Official record key
drug-enforcement:D-0970-2015

Official wording

Reason: Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.

Code information: Lot #: 6A207012, Exp 7/2015.

Distribution pattern: Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Chemical Contamination